Skip to content

Effect of Preoperative Ultrasound-Guided Retrolaminar Block with Liposomal Bupivacaine on Postoperative Pain in Patients Undergoing Thoracoscopic Pulmonary Resection Surgery

Effect of Preoperative Ultrasound-Guided Retrolaminar Block with Liposomal Bupivacaine on Postoperative Pain in Patients Undergoing Thoracoscopic Pulmonary Resection Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127210
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule(s)

Interventions

Ropivacaine group (RO group):Analgesic Effect of Ultrasound-Guided Retrolaminar Block with Ropivacaine in Patients Undergoing Video-Assisted Thoracoscopic Lung Resection
Liposomal bupivacaine group (LB group):Analgesic Effect of Ultrasound-Guided Retrolaminar Block with liposomal bupivacaine in Patients Undergoing Video-Assisted Thoracoscopic Lung Resection

Sponsors

Jiangsu Province Geriatric Hospital(Geriatric Hospital of Naning Medical University, Jiangsu Province Official Hospital, Jiangsu Province Geriatric Hospital Telehealth Services)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–75 years; 2.BMI 19–30 kg/m^2; 3.ASA physical status II or III; 4.Scheduled to undergo elective VATS pulmonary resection under general anesthesia; 5.Able to understand the pain scoring method and comply with follow-up assessments before surgery; 6.Willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.New York Heart Association (NYHA) functional class III or IV; 2.Cardiac conduction block; 3.Unstable coronary artery disease; 4.Insulin-dependent diabetes mellitus; 5.Renal or hepatic dysfunction; 6.Coagulation disorders or use of oral anticoagulants; 7.Alcohol abuse or opioid dependence; 8.Uncontrolled psychiatric disorders (e.g., anxiety, depression, schizophrenia); 9.Pregnancy or planned pregnancy; 10.Significant alteration of local anatomical structures; 11.Or known allergy to local anesthetics or study medications.

Design outcomes

Primary

MeasureTime frame
Cumulative NRS pain scores at rest and during movement within 0–72 hours postoperatively (expressed as the area under the curve, AUC);

Secondary

MeasureTime frame
Activities of daily living at 72 h postoperatively;Time to first initiation of PCIA;postoperative NRS scores at rest and during movement from 0–72 h;total postoperative intravenous opioid and non-opioid consumption within 72 hours after surgery;NRS pain scores during movement at postoperative day 14 and 3 months;QoR-15 score at 72 h postoperatively;Time to first ambulation and chest tube removal postoperatively;

Countries

China

Contacts

Public ContactSiyang Xu

Jiangsu Province Geriatric Hospital(Geriatric Hospital of Naning Medical University, Jiangsu Province Official Hospital, Jiangsu Province Geriatric Hospital Telehealth Services)

xsyjy2020@126.com+86 25 83712838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026